Immuneering
IMRX
IMRX
94 hedge funds and large institutions have $154M invested in Immuneering in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $209M → $154M (-$55.2M)
33% less call options, than puts
Call options by funds: $962K | Put options by funds: $1.43M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
94
Holding in Top 10
1
Calls
$962K
Puts
$1.43M
Top Buyers
| 1 | +$6.59M | |
| 2 | +$5.39M | |
| 3 | +$1.93M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.83M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.37M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$10.9M | |
| 3 | -$4.38M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.09M |
| 5 |
Morgan Stanley
New York
|
-$992K |
